MEANS FOR DEVELOPMENT OF BRAKING carcinomas EHRLICH

摘要

1. The use of beta-etildifatsila as a means for inhibition of Ehrlich carcinoma - proiskhozhdeniya.2 epithelial tumors. Use of beta-etildifatsila according to claim 1, characterized in that the drug is used in doses of 15-50 mg per kg body weight mlekopitayuschego.3. Use of beta-etildifatsila according to claim 2, characterized in that the interval between the injections is 6-7 dney.4 preparation. Use of beta-etildifatsila according to claim 3, characterized in that the treatment is from 2 to 60 days after tumor transplantation.